skip to main content

CHO-K1.Cl-0205

CHO-K1.Cl-0205

Catalogue No.

15042905

Cell Line Name

CHO-K1.Cl-0205

Cell Line Description

Clone of CHO-K1 cells expressing human FcγRIIa of the 131H allotype as a transmembrane protein with its native intracellular domain

General Info

Species

Hamster

Unique to ECACC

Yes

Release Conditions

Restricted - commercial organisations are required to complete the 'Cell Line Release Authorisation for Research Use in Commercial Organisations' release conditions form in the supporting documents section.

Characteristics

Receptors

Fc portion of human IgG antibody

Products

CHO cells expressing human FcγRIIa of the 131H allotype as a transmembrane receptor.

Tissue of Origin

Ovary

Morphology

Polygonal

Karyotype

N/A

Applications

Measurement of IgG binding

Disease

None Stated

Culture Conditions

Cell Type

Epithelial

Subculture Routine

Split sub-confluent cultures (70-80%) 1:3 to 1:6. Seeding at 2-5 x 10,000 cells/cm² using 0.05% trypsin/EDTA; culture conditions 5% CO₂/95% air; 37°C

Culture Medium

EMEM (EBSS) + 2mM Glutamine + 1% Non- Essential Amino Acids (NEAA) + 10% Foetal Bovine Serum (FBS) with 600ug/ml hygromycin B

Growth Mode

Adherent

Additional Info

Depositor

Dr Kathryn L Armour, Cambridge Enterprise

Country of Origin

United Kingdom

GMO Status

Genetically Modified Organism Class 1 (GMO1)

Genetic Modification

Stably transfected with a pcDNA3.1/Hygro(+) based vector with a human FCγRIIIa 131H cDNA insert that is expressed as a transmembrane receptor

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

Armour KL, Smith CS, Turner CP, Kirton CM, Wilkes AM, Hadley AG, Ghevaert C, Williamson LM, Clark MR. Low-affinity Fc gamma R interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets. Eur J Immunol. 2014Mar; 44 (3):905-14. doi: 10.1002/eji.201343825. Epub 2014 Feb 16. PubMed

Bibliography

Armour KL, Smith CS, Ip NC, Ellison CJ, Kirton CM, Wilkes AM, Williamson LM, Clark MR. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS One. 2014 Oct 10;9(10):e109463. doi: 10.1371/journal.pone.0109463. eCollection 2014. PubMed PMID: 25302805; PubMed Central PMCID: PMC4193810. PMID:24285214; PubMed Central PMCID: PMC4209800

Available Formats

  • Frozen
  • DNA-5µg (100ng/µl)

If use of this culture results in a scientific publication, it should be cited in the publication as: CHO-K1.Cl-0205 (ECACC 15042905).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country.

ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.